HDAC8 and glioblastoma: Our results suggest that HDAC8 inhibition (BMX) could overcome TMZ resistance in GBM-R cells by enhancing the TMZ-mediated cytotoxic effect by downregulating the β-catenin/c-Myc/SOX2 signaling pathway and upregulating p53-mediated MGMT inhibition.